Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trialMaria Domenica Cappellini, Alì Taher, Pencho Georgiev et al.|The Lancet Haematology|2025Cited by 17